Tonix Pharmaceuticals Ownership | Who Owns Tonix Pharmaceuticals?


OverviewForecastRevenueFinancialsChartTranscripts

Tonix Pharmaceuticals Ownership Summary


Tonix Pharmaceuticals is owned by 68.69% institutional investors, 0.13% insiders, and 31.19% retail investors. Blackrock funding, inc. /de is the largest institutional shareholder, holding 10.20% of TNXP shares. Vanguard Total Stock Mkt Idx Inv is the top mutual fund, with 3.06% of its assets in Tonix Pharmaceuticals shares.

TNXP Ownership Benchmark


TypeName% Inst% Insiders% Retail
StockTonix Pharmaceuticals68.69%0.13%31.19%
SectorHealthcare Stocks 50.49%12.37%37.14%
IndustryBiotech Stocks 48.95%12.07%38.98%

Institutional Shareholders


Top Institutional Shareholders by Total Shares

HolderShares% HoldingValue
Blackrock funding, inc. /de1.40M10.20%$17.84M
Point72 asset management1.17M8.51%$14.89M
Vanguard group673.61K7.55%$10.52M
Millennium management966.93K7.05%$12.34M
Aqr capital management882.60K6.44%$11.26M
Vanguard capital management691.89K5.05%$8.83M
Geode capital management395.26K2.88%$5.04M
State street271.37K1.98%$3.46M
Ubs group231.68K1.69%$2.96M
Citadel advisors195.86K1.43%$2.50M

Top Institutional Shareholders by % of Total Assets

HolderShares% AssetsValue
Superstring capital management lp63.65K0.51%$812.15K
Essex investment management165.14K0.28%$2.11M
Legato capital management55.62K0.06%$709.71K
Quarry lp41.25K0.04%$526.35K
Xtx topco20.30K0.03%$490.35K
Point72 asset management1.17M0.02%$14.89M
Sjs investment consulting10.20K0.01%$130.20K
Susquehanna portfolio strategies65.02K0.01%$829.71K
Ieq capital92.37K0.01%$1.18M
Trexquant investment lp63.63K0.00%$811.98K

Top Buyers

HolderShares% AssetsChange
Point72 asset management1.17M0.02%1.04M
Millennium management966.93K0.00%747.26K
Aqr capital management882.60K0.00%721.39K
Blackrock funding, inc. /de1.40M0.00%429.86K
Vanguard capital management691.89K0.00%173.25K

Top Sellers

HolderShares% AssetsChange
Citadel advisors195.86K0.00%-272.85K
Balyasny asset management132.59K0.00%-180.49K
Davidson kempner capital management lp---90.01K
Squarepoint ops---31.63K
Jane street group---30.63K

New Positions

HolderShares% AssetsChangeValue
Essex investment management165.14K0.28%165.14K$2.11M
Susquehanna portfolio strategies65.02K0.01%65.02K$829.71K
Trexquant investment lp63.63K0.00%63.63K$811.98K
Capital fund management62.95K0.00%62.95K$1.52M
Jacobs levy equity management57.94K0.00%57.94K$739.35K

Sold Out

HolderChange
Raymond james financial-7.00
Wealth preservation advisors-55.00
Root financial partners-60.00
Mai capital management-141.00
Pinnacle wealth planning services-342.00

Institutional Ownership Trends


DateHoldingsChange %SharesChange %OwnershipChange %Increased PositionChange %Decreased PositionChange %
Jun 30, 202610824.14%9,415,07193.36%685.44%8155.77%7-56.25%
Mar 31, 202635-53.33%1,130,973-69.78%130.76%21-60.38%5-37.50%
Dec 31, 202548-22.58%2,487,1385.52%272.69%33-25.00%5-28.57%
Sep 30, 20256042.86%2,353,52474.63%329.49%4330.30%716.67%
Jun 30, 20254684.00%1,387,046186.68%1828.41%37164.29%6-45.45%

Top Mutual Funds Shareholders


HolderShares% HoldingChange
Vanguard Total Stock Mkt Idx Inv488.11K3.06%80.40K
Vanguard Morn Total Stk Mkt Idx Investor488.11K3.06%80.40K
Vanguard MStar Total Stk Mkt Idx Invest488.11K2.91%-
iShares Russell 2000 ETF381.41K2.39%-6.82K
Fidelity Enhanced Small Cap Core ETF180.76K1.13%695.00
Vanguard Institutional Extnd Mkt Idx Tr187.41K1.12%-
Nuveen Quant Small Cap Equity R681.40K0.93%81.40K
iShares Russell 2000 Value ETF143.49K0.90%-
Fidelity Small Cap Index138.38K0.87%4.11K
Russell 2000 Equity Index Fund B107.58K0.67%34.10K

Recent Insider Transactions


DateNameRoleActivityValue
Aug 20, 2026BAGGER RICHARD H-Buy$12.60K
Jun 12, 2026Taylor Carolyn E.-Buy$14.93K
Jun 08, 2026Stillwell Richard Newcomb-Buy$58.25K
Jun 09, 2026LEDERMAN SETH Chief Executive OfficerBuy$58.95K
Mar 31, 2026LEDERMAN SETH Chief Executive OfficerBuy$63.10K

Insider Transactions Trends


DateBuySell
2026 Q22-
2026 Q12-
2025 Q4--
2025 Q32-
2025 Q21-

TNXP Ownership FAQ


Who Owns Tonix Pharmaceuticals?

Tonix Pharmaceuticals shareholders are primarily institutional investors at 68.69%, followed by 0.13% insiders and 31.18% retail investors. The average institutional ownership in Tonix Pharmaceuticals's industry, Biotech Stocks , is 48.95%, which Tonix Pharmaceuticals exceeds.

Who owns the most shares of Tonix Pharmaceuticals?

Tonix Pharmaceuticals’s largest shareholders are Blackrock funding, inc. /de (1.4M shares, 10.20%), Point72 asset management (1.17M shares, 8.51%), and Vanguard group (673.6K shares, 7.55%). Together, they hold 26.26% of Tonix Pharmaceuticals’s total shares outstanding.

Does Blackrock own Tonix Pharmaceuticals?

BlackRock is not among the top 10 institutional shareholders of Tonix Pharmaceuticals.

Who is Tonix Pharmaceuticals’s biggest shareholder by percentage of total assets invested?

Superstring capital management lp is Tonix Pharmaceuticals’s biggest shareholder by percentage of total assets invested, with 0.51% of its assets in 63.65K Tonix Pharmaceuticals shares, valued at 812.15K$.

Who is the top mutual fund holder of Tonix Pharmaceuticals shares?

Vanguard Total Stock Mkt Idx Inv is the top mutual fund holder of Tonix Pharmaceuticals shares, with 3.06% of its total shares outstanding invested in 488.11K Tonix Pharmaceuticals shares.

Try Tickergate Pro Free

Customize Everything. 100% Flexibility. Fast and Easy to Use (No code or Excel Needed)

  • Customize your own personal stocks lists, views and charts

  • Choose from hundreds of fields, up to 15 years of history

  • Conduct deep comparison analysis

  • Discover trending investment themes

  • Find your next best investment

  • Research stocks using tools